| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |